Pediatrics News

ORLANDO — In this Healio Video Perspective from Vision Expo East, Yair Yahav, CEO and founder of RevitalVision, discusses the U.S. launch of the company’s neurological therapy indicated to improve vision outcomes across various conditions.

ORLANDO — One year after its launch, the World Council of Optometry CooperVision Myopia Management Navigator app is being used in more than 100 countries spanning the globe, according to the Americas ambassador for the program.

Children who wore soft multifocal contact lenses for myopia control had no loss of treatment effect after discontinuing the lenses as teenagers, according to a study published in JAMA Ophthalmology.

Red light therapy, a relatively new treatment option, has made waves recently as studies investigate its potential for controlling myopia in children.

This year, Healio covered several studies and updates about treatment options to slow myopia progression, including one about a model developed to predict the onset of myopia.

InfantSEE, a program managed by the American Optometric Association Foundation that provides no-cost, comprehensive eye and vision care for infants, announced that it has completed 172,000 assessments since its founding in 2005.

Low-level red light therapy was superior to orthokeratology lenses at slowing myopia progression in children in the first year of treatment, though the difference was not significant in the second year, according to study results.

Eyenovia’s phase 3 CHAPERONE study evaluating low-dose atropine delivered via the company’s Optejet dispenser is not meeting its primary endpoint of a less than 0.50 D progression in visual acuity over 3 years, according to a press release.

INDIANAPOLIS — Dry Eye Questionnaire-5 scores did not appear to align with ocular signs of dry eye in pediatric patients, highlighting the need for diagnostic tools tailored for children, according to a poster at Academy 2024.